HilleVax Reports First Quarter 2023 Financial Results and Hi

BOSTON, May 12, 2023 -- HilleVax, Inc. , a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial results for the quarter ended... | May 12, 2023

Related Keywords

Ukraine , Boston , Massachusetts , United States , Russia , Nanette Cocero , Rob Hershberg , Shane Maltbie , Nasdaq , Takeda Vaccines Inc , Exchange Commission , Hillevax Inc , Chief Executive Officer , Norovirus Efficacy , Safety Trial , Takeda Vaccines , Private Securities Litigation Reform Act , Consolidated Statement , Hillevax , Nc Stock Exchange , News , Information , Press Release , Bay , 023 , Iopharmaceutical , Company , Ocused , N , Developing , End , Commercializing , Novel , Oday , Eported , Financial , Results , Or , The , Uarter Hlvx Us43157m1027 ,